ron squarer  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors ron squarer check out list of companies and businesses related to ron squarer find out ron squarer address and contact details view other people related to ron squarer  coworkers colleagues companions etc address  north field drive lake forest  il companies related to ron squarer cikcompany namepositioncompany addressarray biopharma incceo  walnut street boulder hospira incchief commercial officer  field dr lake forest retrophin incdirector  valley centre dr suite  san diego  ron squarer on the web persons related to ron squarer  array biopharma incnamepositioncitycharles m baumdirector san diegocharles m baumdirector boulderbiotechnology value fund ii lpchicagobiotechnology value fund ii lpchicagobiotechnology value fund ii lpchicagobiotechnology value fund l pchicagobiotechnology value fund l pchicagofrancis j bullockdirector lincolnfrancis j bullockdirector boulderbvf incilchicagobvf incilchicagobvf incilchicagobvf investments llcchicagobvf investments llcchicagobvf investments llcchicagobvf partners l pil owner chicagobvf partners l pilchicagobvf partners l pil chicagomichael carrutherscfo bouldermichael carrutherschief financial officer bouldermichael carrutherscfo bouldermichael carrutherscfo bouldermarvin h caruthersdirector bouldermarvin h caruthersdirector boulderrobert conwayceo boulderrobert conwayceo bouldersnitnam davidboulderwilliams douglasboulderbullock francisbouldergwen a fyfe sunnyvalegwen a fyfedirector bouldervan lunsen gilboulderjeremy greensan franciscojason haddockcfo bouldermary p henahanboulderdavid j horinnewport beachzabriskie johnbouldermoore johnboulderkoch kevinboulderkevin kochpresident cso boulderkevin kochpresident  cso boulderlefkoff kylebouldermark n lampertchicagomark n lampertchicagomark n lampertsan franciscokyle lefkoffdirector boulderkyle lefkoffboulderkyle lefkoffdirector boulderkyle lefkoffdirector boulderkyle lefkoffdirector bouldercaruthers marvinboulderjohn r moorevp general counsel boulderjohn r moorevp general counsel boulderjohn r moorevp general counsel bouldermichael n needlecmo bouldermichael n needlecmo boulderjohn a orwin san mateojohn a orwindirector san mateojohn a orwindirector redwood citytony piscopiovice president chemistry bouldercarruthers rboulderliam ratcliffedirector new yorkliam ratcliffedirector new yorkredmile group llc owner san franciscoandrews r robbinscoo boulderandrews r robbinssvp commercial operations boulderconway robertbouldernicholas a saccomanocso bouldernicholas a saccomanocso bouldervictor sandorchief medical officer bouldershalini sharpnew yorkdavid snitmancoo and vp business devel boulderdavid snitmancoo and vp bus development boulderdavid snitmancoo and vp business devel boulderron squarerceo lake forestron squarerboulderron squarerceo boulderron squarerceo boulderlunsen gil j vandirector durangolunsen gil j vandirector boulderlunsen gil j vandirector boulderlunsen gil j vandirector boulderlunsen gil j vandirector boulderdouglas e williamsdirector bothelldouglas e williamsdirector boulderjohn yatescmo boulderjohn l zabriskiedirector boulderjohn l zabriskiedirector bostonpersons related to ron squarer  hospira incnamepositioncitylaboratories abbott owner abbott parkjoel t allisondirector lake forestjohn arnottsvp global comm operations lake forestjohn arnottsvp global comm operations lake forestjohn arnottsvp global comm ops lake forestirving w bailey iidirector el segundoirving w bailey iidirector lake forestirving w bailey iidirector lake forestirving w bailey iidirector lake forestf michael ballchief executive officer lake forestf michael ballchief executive officer lake forestf micheal ballchief executive officer irvineroyce bedwardsvp general counsel and secy lake forestchristopher b begleylake forestchristopher b begleychief executive officer lake forestchristopher b begleychairman and ceo lake forestbarbara l bowlesdirector barbara l bowlesdirector lake forestconnie r currandirector lake forestconnie r currandirector lake forestconnie r currandirector lake forestrichard john daviessvp chief commercial officer lake forestrichard john daviessvp chief commercial officer lake forestwilliam g dempseydirector abbott parkwilliam g dempseydirector lake forestfrancois l duboissenior vice president quality lake forestjohn b elliotsvp operations lake forestdavid j endicottpres hospira medical devices irvinedavid j endicottpres hospira medical devices lake forestdennis m fentondirector dennis m fentondirector lake forestthomas c freymanabbott parkthomas c freymanabbott parkmary gendronsvp chief information officer lake forestroger w haledirector roger w haledirector lake forestjames h hardy jrsvp operations lake forestrichard j hoffmancvp controller  cao lake forestrichard j hoffmancvp controller  cao lake forestdaphne e jonessvpchief information officer lake forestdaphne e jonessvp chief information officer lake forestdavid a srky jonesdirector lake forestdavid a srky jonesdirector lake forestdavid a srky jonesdirector lake forestdavid a srky jonesdirector lake forestzena g kaufmansvp quality lake forestzena g kaufmansvp quality lake forestterrence c kearneysvp finance and cfo lake forestterrence c kearneysvp finance and cfo lake forestterrence c kearneychief operating officer lake forestronald a matricariadirector lake forestkenneth f meyerssvp chief human resources ofr lake forestkenneth f meyerssvp chief human resources ofr lake forestedward a ogunrosvp and chief scientific off lake forestedward a ogunrosvp and chief scientific off lake forestedward a ogunrosvp lake forestjudith c pelhamdirector lake forestjudith c pelhamdirector lake forestsumant ramachandrasvp  chief scientifc ofcr lake forestneil rydingsvp devices lake forestbrian j smithsvp and special counsel lake forestbrian j smithsvp gc and secretary lake forestbrian j smithsvp chief legal officer lake forestbrian j smithsvp and special counsel lake forestjacque j sokolovdirector charlottejacque j sokolovdirector lake forestjacque j sokolovdirector lake forestron squarerchief commercial officer lake forestjohn c staleydirector john c staleydirector lake forestjohn c staleydirector lake forestmatthew r stobersvp operations lake forestprondzynski heino vondirector lake forestwilliam l weissdirector lake forestwilliam l weissdirector lake forestthomas e wernersvp finance  cfo lake forestmark f wheelerdirector seattlemark f wheelerdirector lake forestmark f wheelerdirector lake forestvalentine yiencvp and controller lake forestvalentine yiencvp and controller lake forestvalentine yiencorp vp controller lake forestmarc j yoskowitzsvp strategy  corporate dev lake forestpersons related to ron squarer  retrophin incnamepositioncitysteve aselagechief executive officer seattlesteve aselagechief executive officer new yorksteve aselagepresident and coo new yorkroy d baynesdirector san diegobroadfin capital llcnew yorkbroadfin healthcare master fund ltdgrand caymanlaura claguechief financial officer san diegolaura claguechief financial officer new yorktimothy p coughlindirector san diegocornelius e goldingdirector freeholdcornelius e goldingdirector new yorkcornelius e goldingdirector new yorkplotkin horacionew yorkkevin kotlernew yorkjohn w kozarichdirector san diegogary a lyonsdirector palo altogary a lyonsdirector new yorkpanoff marcnew yorkshkreli martinnew yorkneil f mcfarlanechief operating officer san diegojeffrey a mecklerdirector new yorkjeffrey a mecklerdirector new yorkopaleye gp llccambridgejohn a orwindirector san mateojeffrey paleydirector new yorkmarc l panoffnew yorkmarc l panoffchief financial officer new yorkhoracio plotkinchief medical officer new yorkhoracio plotkinchief medical officer new yorkelizabeth e reedsvp gc  corporate secretary san diegosteven gary richardsondirector new yorksteven gary richardsondirector new yorkwilliam e rotesenior vice president rd san diegoruth shepleythe woodlandsalvin shihevp of research  development new yorkmartin shkrelichief executive officer new yorkmartin shkrelichief executive officer new yorkmartin shkreli new yorkron squarerdirector lake forestaselage stephennew yorkrichardson stevenew yorkjensen margaret e valeurgeneral counsel san diegojensen margaret e valeurgeneral counsel new york array biopharma ceo developing products ourselves x times times times times to view this site you need to have javascript enabled in your browser and either the flash plugin or an htmlvideo enabled browser download the latest flash player and try again array biopharma ceo developing products ourselves friday  sep   0 pm et mad money host jim cramer calls array biopharma a spec play the company has  trials in phase  in progress its ceo ron squarer discusses its partnerships with big players including novartis and celgene watch cnbc live tv shares you may like ‹› top video ‹     mins ago this one report out on monday is a key indicator for the economy        hrs ago post new yorker rant this video of anthony scaramucci on choosing your words is amazing    00 00  jul   heres why a bitcoinira is enticing some to risk their savings        hrs ago startups are uberfying the private jet market    0 0   hrs ago why starbucks is closing all  teavana locations by next spring        hrs ago ombs mick mulvaney senate cant go home without doing something        hrs ago nasdaq weakness likely to stretch into second day        hrs ago cramer remix these stocks aren’t cool but they could heat up your portfolio       jul   why the gdp report could have a massive effect on the market       jul    ways to trade the amazon slump    0 0  jul   foxconn is investing  billion in the us       jul   here’s how amazon stock briefly made jeff bezos the world’s richest man       jul   why its harder than ever to land a hamptons beach house    0 0  jul   here is why investors should watch crude oil prices    0 0  jul   heres what some analysts expect from amazons earnings today       jul   jeff bezos now the worlds richest man based on stock wealth       jul   the man who predicted the dotcom bubble calls bitcoin a pyramid scheme       jul   product review turn up the volume on your amazon echo dot  take it anywhere with vaux       jul   why this weeks earnings reports are a big deal for the market       jul   passage of gops skinny obamacare bill appears slim       jul   facebook shares jump on big earnings beat       jul   wall street sitting at fresh record highs       jul   cramer remix the one earnings report that can turn one of the market’s most important sectors around    0 0  jul   gilead surges after hours       jul   dow reaches record high after fed leaves interest rates unchanged    0 0  jul   companies across the board benefit from cryptocurrency    0 0  jul   rick perry was duped into a fake interview with russian pranksters       jul   fed leaves rates balance sheet policy unchanged       jul   elon musk unveils the boring companys car elevator for superhighway project       jul   white house to announce applesupplier foxconn manufacturing plant in wisconsin on wednesday source    › latest video ‹     mins ago reince priebus out as white house chief of staff        mins ago spacex is now worth  billion        hr ago starbucks brands suffering from slowing mall traffic        mins ago this one report out on monday is a key indicator for the economy    0 0   mins ago jeff immelt emerges as candidate for uber ceo wsjs greg bensinger        mins ago large draws in oil helped propel prices higher iaf advisors kyle cooper    0 0   hr ago the power of apple is the ecosystem newberger bermans daniel flax        hr ago the week ahead earnings from big names like apple tesla        hr ago the week that was healthcare reform fails    0 0   hr ago dow hits a new record close        hr ago dow posts record close after busy earnings week    00 00   hr ago these  stock could see big moves on earnings    0 0   hr ago the full interview with john stoltzfus        hr ago oppenheimer strategist john stoltzfus makes the bull case        hr ago jury deliberation for martin shkreli begins monday    0 0   hr ago should google facebook be regulated like utilities        hr ago military options discussed by joint chiefs chair after north korean missile launch        hrs ago a key government perk for tesla buyers is running out says edmunds    0 0   hrs ago gop senators who blocked obamacare repeal call for cooperation with democrats        hrs ago apple could save the day for tech stocks and the market        hrs ago headed to a concert or game watch out for ticket scams        hrs ago ai bots        hrs ago supermarket savings        hrs ago cancer innovations        hrs ago money for nothing        hrs ago why are event tickets so hard to come by sometimes        hr ago commodities tomorrow crude nears 0 threshold    0 0   hr ago investors want us to keep delivering intel cfo bob swan    0 0   hr ago  moments the profit’s marcus lemonis rolled up his sleeves    0 0   hrs ago closing bell exchange market needs new leadership    › make it dreamers seekers and gamechangers ‹    jul   suzy welch these red flags tell you to act fast to leave a failing company       jul   it scares the s out of me billionaire mark cuban says of ai    0 0  jul   this is what malcolm gladwell learned from being fired two months into a job        hrs ago one woman paid off over 0 in credit card debt in 0 days—heres how she did it       jul   this m ferrari gto is a car only a multimillionaire can afford       jul   why millennials are making a huge mistake by not using credit cards more often       jul   this is how much education you need to land a job at the worlds biggest tech companies       jul   judging dogs as a joke became a sixfigure business for this college student    0 0  jul   jeff bezos is the world’s richest person    0 0  jul   hondas futuristic concept car has artificial intelligence and wants to know how youre feeling       jul   this car made from hemp cannabis is stronger than steel       jul 0   sumptuous meals only the superrich can afford       jul   marcus lemonis how to show youre ready for more responsibility at work    0 0  jul   marcus lemonis gives president trump some social media pointers       jul   simple ways to grow your savings without changing your life    0 0  jul   sunbeam tiger bought for 0 now has a jawdropping value       jul   richard reeves the american dream is in danger    0 0  jul   learn warren buffett’s simple psychological trick to being persuasive       jul   kevin durant took a nearly  million pay cut — heres why       jul   suzy welch why this trait is a career killer       jul   heres how nba star draymond green plans to be a billionaire by 0       jul   marcus lemonis confident management is essential to success at a small business       jul   harvard study almost 0 million americans cant afford to pay for housing       jul   suzy welch  linkedin hacks that will get you hired       jul   how daymond john went from waiting tables at red lobster to creating a  billion urban clothing brand       jul   mark zuckerberg and elon musk share this top personality trait says ibm supercomputer       jun   this ceo says the future of car manufacturing is d printing    0 0  jul   mark zuckerberg alaskas cash handout program provides some good lessons for the rest of the country       jun   think youre middle class you might be wrong    0 0  jun   memorize anything with ease using this technique from usa memory champion nelson dellis    › cramer remixed ‹     hrs ago cramer remix these stocks aren’t cool but they could heat up your portfolio       jul   cramer remix the one earnings report that can turn one of the market’s most important sectors around       jul   cramer remix why investors shouldn’t abandon alphabet    0 0  jul   cramer remix the jig is up signs that us oil producers could be slowing down    0 0  jul 0  cramer remix amazon is king whether you like it or not       jul   cramer remix snap is the no  reason to own facebook       jul   cramer remix don’t let the action in unitedhealth fool you    0 0  jul   cramer remix why it’s still worth owning procter  gamble    0 0  jul   cramer remix target’s news flash is good for shareholders but it might not be enough for all of retail    0 0  jul   cramer remix this stock is just too sexy to ignore       jul   why snap can’t snap back anytime soon       jul   cramer remix not just fun and games this stock is the real deal       jul   cramer remix how the legalization of marijuana could give brinks a boost    0 0  jul   cramer remix the boring noname unsung stock that’s been a huge winner    0 0  jul   cramer remix don’t roll your eyes at this massive marketmoving trend       jun   cramer remix why age is just a number when it comes to investing       jun   cramer remix the most controversial earnings report next week       jun   cramer remix the biggest winner of amazon’s destruction of the mall       jun   cramer remix these stocks are downright painful to own       jun 0  cramer remix why the fed needs to pay attention to amazon’s rampage    0 0  jun   cramer remix the energy deal that could bring fortunes to shareholders    0 0  jun   cramer remix the no  stock to own when the market sentiment changes       jun   cramer remix why the fed has become a paragon of predictability    0 0  jun   cramer remix one stock that could benefit big from the us oil glut       jun   cramer remix this is the stock to own for the summer    0 0  jun   cramer remix why it’s vital the fed raises rates    0 0  jun   cramer remix why apple is the best consumer products company in history       jun   cramer remix what the dreaded rise in stocks gold  bitcoin means for your money       jun   cramer remix heres what’s really killing retail       jul   cramer remix the key stock patterns every investor should know    › microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext0 where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within 0 days ext0 personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext0 legal privacy  cookies   microsoft unavailable  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries this feature is temporarily unavailable copyright – fmr llc  all rights reserved  terms of use privacy security site map  stock market research top stocks quotes  news  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas you are here stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries stock research center not a fidelity customer no problem try our research for free without opening an account   trending stocks market movers top rated by sector orders by fidelity customers filters refresh equity summary score provided by starmine investing insights technical events provided by recognia as of 0 methodology recognia methodology bullish and bearish events of the day provide longshort trading ideas by identifying us stocks that have recently formed a bullish or bearish classic chart pattern patterns must have taken at least  days to form which draws out the more significant patterns for intermediate or longterm trend direction the list is then filtered to include stocks with a minimum  for bullish and  for bearish close price and a minimum 00 trading volume most recent patterns are listed first patterns on the same date are sorted using recognias proprietary quantitative algorithm to draw strong companies to the top and if further sorting is required for stocks with the same quantitative analysis result it is done by trading volume to draw highest volume stocks to the top vz log in for events urbn urbn syna ll hp log in for events alks cvrr cvrr esnd find out how to use fundamental analysis and technical analysis when evaluating stocks with the help of the fidelity learning center my research –  organize and track your favorite securities get started todays events as of  pm et 0 earnings  dividends 0 splits  upgrades  downgrades  economic  upcoming webinar events visit the learning center events page for a full list of upcoming webinars the equity summary score is provided for informational purposes only does not constitute advice or guidance and is not an endorsement or recommendation for any particular security or trading strategy the equity summary score is provided by thomson reuters starmine an independent company not affiliated with fidelity investmentsgics® global industry classification standards is an industry classification system developed by standard  poors in collaboration with morgan stanley capital international msci sp uses gics to determine the market segment to which a company is assignednews commentary including related symbols and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their usestock markets especially foreign markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments sector funds can be more volatile because of their narrow concentration in a specific industrysystem availability and response times may be subject to market conditionsthe fidelity screeners are research tools provided to help selfdirected investors evaluate securities the criteria and inputs entered are at the sole discretion of the user and all screens or strategies with preselected criteria are solely for the convenience of the user information supplied or obtained from the screeners is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell securities or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy or approach to screening or evaluating stocks preferred securities exchange traded products or closed end funds fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their use determine which securities are right for you based on your investment objectives risk tolerance financial situation and other individual factors and reevaluate them on a periodic basis copyright – fmr llc  all rights reserved  terms of use privacy security site map  ron squarer search search home newsnewspharmaceutical newsbiotechnology newsgenerics newsbiosimilars newsmergers  acquisitionsregulationworld newstop news stories combo approved in eu across major hcv genotypesbiotechnologykeytruda key to merck  co’s estimatetopping profitspharmaceutical in depthin depthanalysisspecial reportinterviewin conversation with expert viewfrom our correspondentin the boardroomtop in depth stories after  years of failure what can pharma offer alzheimers patientspharmaceuticalpatient centricity making clinical trials more effective by keeping focus on the patientpharmaceutical conference roundupconference roundupaaic eular easl asco aacr annual meeting ectrims top conference roundup stories combo approved in eu across major hcv genotypesbiotechnologykeytruda key to merck  co’s estimatetopping profitspharmaceutical focus onfocus onbrexitfdapricingemarussian markettrump administrationtop focus on stories inquiry asks how to stimulate uk life sciences innovationpharmaceuticalbrexit and longerterm sector trends could boost uk pharma mainvestmentbiotechnology events companies reports ron squarer chief executive officer chief executive officer ron squarer has served as chief executive officer and a member of the array board of directors since april  mr squarer has extensive commercial development and executive leadership expertise from a 0 year career in the pharmaceutical industry most recently he served as chief commercial officer at hospira a global pharmaceutical and medical device company where he was responsible for delivering  billion in annual revenue and leading more than 0 employees worldwide prior to this mr squarer was responsible for strategy new product development and commercialization acquisitions partnerships and portfolio prioritization as senior vice president global marketing and corporate development mr squarer joined hospira from mayne pharma an oncologyfocused global pharmaceutical company where he served as senior vice president global corporate and business development when mayne was sold to hospira for  billion in  earlier mr squarer held senior management roles at both pfizer inc focused on global oncology commercial development and at smithkline beecham pharmaceuticals now glaxosmithkline in the us and europe mr squarer holds an mba from the kellogg school of management northwestern university and a bachelor’s degree in biochemistry from the university of california berkeley related pharma letter news array files two drugs for approval in metastatic melanomaarray and bristolmyers in new combination therapy collaborationmerck and array to test keytruda in combo with binimetinib more pharma letter news editors picks most read top  stories of in alzheimers the juggernaut is changing course says taurx chief execepigenetic biomarkers set to make “a huge difference in human health” says cambridge epigenetix’s tiffany morrisemachmp recommends eight new drugs for approval including five orphansbrexit and longerterm sector trends could boost uk pharma mainvestmentsuccess of chinese pilot a step forward in the ‘globalization of drug regulation’top  stories of lonza and sanofi to build new multidisciplinary biomanufacturing facility in switzerlandnice recommends treatment with daxas for copdchiesi cleared to market copd drug in europefacing budget pressure china furthers drug price cuts and pushes reimbursement reformafter  years of failure what can pharma offer alzheimers patients company spotlightzymeworkszymeworks is a clinicalstage biopharmaceutical company dedicated to the discovery development and commercialization of nextgeneration multifunctional biotherapeutics initially focused on the treatment of cancer tweets sign up for our daily newsletter our latest news direct to your inbox newsletter back to top array biopharma  management team contact us  careers go menu homeabout usmanagement teamboard of directorscontact uspipelinebinimetinibencorafenib lgxselumetinibother programsclinical trialsdiscovery collaborationsarray discovery capabilitiesselected collaborationscontact uspublicationsinvestorsstock informationnews  eventsfinancialscorporate governanceshareholder services search go management team ron squarerchief executive officer ron squarer has served as chief executive officer and a member of the array board of directors since april  mr squarer has extensive commercial development and executive leadership expertise from a greater than two decade career in the biopharmaceutical industry prior to this mr squarer held positions of increasing responsibility with hospira inc a global pharmaceutical and medical device company most recently serving as senior vice president chief commercial officer where he was responsible for delivering  billion in annual revenue  mr squarer joined hospira from mayne pharma where he served as senior vice president global corporate and business development when mayne was sold to hospira in   prior to mayne pharma mr squarer held senior management roles at both pfizer inc and at smithkline beecham pharmaceuticals now glaxosmithkline in the us and europe mr squarer currently serves as a member of the board of directors of retrophin inc mr squarer holds an mba from the kellogg school of management northwestern university and a bachelor’s degree in biochemistry from the university of california berkeley jason haddockchief financial officer mr haddock joined array as chief financial officer in july  he has more than  years of financial and operational experience in the biopharmaceutical industry mr haddock held leadership positions of increasing responsibility at bristolmyers squibb a global pharmaceutical company with a strong focus on immunooncology therapies during that time he served in variety of accounting planning commercial analytical and business development capacities for highgrowth business units including head of finance for the worldwide commercialization and medical teams mr haddock also served as executive director for the us pharmaceutical unit where he focused on designing and implementing a completely new business model and operations to capitalize on future product portfolio changes and market developments mr haddock most recently served as chief financial officer and chief operating officer of berg health an oncology focused research diagnostics and development company where he oversaw the implementation of financial and operational processes procedures and policies to transform and scale the company’s practices as it planned for growth and corporate evolution mr haddock earned his undergraduate degree in accountancy from illinois state university and is a certified management accountant he holds an mba from washington university in st louis where he completed the executive program john r moorevice president  general counsel mr moore has served as vice president and general counsel since may  and as secretary since october  prior to joining array mr moore was an associate for three years with the law firm wilson sonsini goodrich  rosati where he negotiated transactions involving technology intellectual property matters and products prior to that mr moore was an associate with the law firms kenyon  kenyon and arnold white  durkee where he focused on intellectual property matters he currently serves on the board of directors of nivalis therapeutics nasdaq nvls mr moore received a jd from the university of north carolina at chapel hill an ms in biochemistry from the university of illinois at urbanachampaign and a bs in chemistry from the university of north carolina at chapel hill victor sandor mdchief medical officer dr victor sandor has served as chief medical officer since september   dr sandor has more than a decade of experience in the pharmaceutical and biotechnology industries  prior to joining array he was senior vice president for global clinical development at incyte corporation  in this role he was instrumental in the development approval and commercialization of jakafi® ruxolitinib the first jak inhibitor while leading clinical development clinical operations medical affairs and biostatistics across the entire portfolio including responsibility for several novel mechanisms including pik cmet and ido inhibitors  prior to incyte dr sandor was vice president and chief medical officer for oncology at biogen idec  he previously held positions of increasing responsibility in oncology product development at astrazeneca where he played an important role in the registration of arimidex® anastrozole for adjuvant use the development of faslodex® fulvestrant injection and the development of several early stage programs through proof of concept  dr sandor received his md cm from mcgill university in montreal canada and completed his fellowship in medical oncology at the national institutes of health in bethesda maryland andrew robbinschief operating officer andrew robbins has served as chief operating officer since march  and previously served as senior vice president of commercial operations since july  mr robbins has extensive commercial development and strategic leadership expertise from a year career in the pharmaceutical industry with a specific focus on oncologyhematology products most recently he was at hospira inc where he served as general managervice president of the us alternate site business unit focused on the sales of pharmaceuticals and medical devices to outpatient oncology surgery pain and dialysis customers in this role he led a team of approximately 0 employees including a national sales force to deliver over  million in annual revenue prior to this he was vice president of corporate development and was responsible for global branded pharmaceutical marketing and business development research and development portfolio prioritization global strategy and corporate venture investing during his tenure he designed and executed a strategy to build a latestage hematologyoncology and acute pain pipeline via licensing and acquisition mr robbins also served on the board of directors for three venturebacked healthcare companies two of which were focused on innovative hematologyoncology products before hospira mr robbins was a commercial leader within pfizer’s oncology unit responsible for shepherding a portfolio of  preclinical and clinical stage products through development using a “fasttopatient” approach several of these products including sutent® sunitinib inlyta® axitinib and xalkori® crizotinib have been commercialized mr robbins holds an mba from the kellogg school of management northwestern university and a bachelors degree from swarthmore college nicholas a saccomano phdchief scientific officer dr nicholas a saccomano has served as chief scientific officer since may   dr saccomano is a seasoned leader with 0 years of experience in pharmaceutical and biotechnology research and development with expertise in discovery research clinical development portfolio strategy technology and clinical candidate licensing and scientific partnering  dr saccomano most recently served as chief technology officer at somalogic inc and as chief scientific officer at bend research inc  while at pfizer inc dr saccomano held positions of increasing responsibility including senior vice president in the rd organization and vice president of discovery technology  as head of discovery technology he managed and developed a diverse set of enabling technologies used broadly across the drug discovery pipeline  during his tenure he also directed medicinal sciences drug discovery and strategic alliances  dr saccomano obtained his phd in chemistry from columbia university under the direction of professor gilbert stork kimberly popevice president human resources ms kimberly pope has served as vice president of human resources since january   ms pope has extensive human resource business and leadership experience in the healthcare and technology industries including  years with abbott laboratories and hospira inc she started at abbott laboratories in the talent acquisition group and later transitioned to hospira  at hospira ms pope held leadership positions of increasing responsibility including director of human resources for global marketing for global information technology and for global operations  in the operations role she was responsible for the hr business partner relationships for the global api pharmaceutical business program management global engineering manufacturing science and technology and the technical professional development program  in addition her business strengths allowed her to play a key role in a major acquisition in india including the building of the largest injectable medicine facility in the world  most recently ms pope was group vice president human resources at idex corporation a global leader in applied engineering solutions specializing in health and science technologies among other diversified products  in her role she supported a global team of  associates across  sites where she had responsibility for talent management talent acquisition organizational effectiveness and driving culture change throughout the business ms pope holds a bachelor of business administration degree from the university of iowa and is a senior professional in human resources from the human resource certification institute  about usmanagement teamboard of directorscontact us homeabout usmanagement teamboard of directorscontact uspipelinebinimetinibencorafenib lgxselumetinibother programsclinical trialsdiscovery collaborationsarray discovery capabilitiesselected collaborationscontact uspublicationsinvestorsstock informationnews  eventsfinancialscorporate governanceshareholder services    array biopharma all rights reserved privacy policy  legal